NCT04459273 2026-02-05FAPI PET RDRCJonsson Comprehensive Cancer CenterPhase 1 Active not recruiting26 enrolled
NCT02862275 2025-10-23Atezolizumab in Treating Patients With Cancer Following Adoptive Cell TransferNational Cancer Institute (NCI)Phase 1 Active not recruiting40 enrolled
NCT04605614 2022-06-0964Cu-DOTA-pembrolizumab PET for the Study of PD1 ExpressionCity of Hope Medical CenterPhase 1 Withdrawn
NCT00070239 2013-12-16Alvocidib in Treating Patients With Metastatic or Unresectable Refractory Solid Tumors or Hematologic MalignanciesNational Cancer Institute (NCI)Phase 1 Terminated100 enrolled